HTFL Heartflow, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · Market cap: $4.2B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $1.1M | $0 |
| 2026-Q1 | $0 | $61.0M |
| 2026-Q2 | $0 | $64.0M |
| 2026-Q3 | $0 | $13.1M |
| 2026-Q4 | $0 | $5.6M |
Bought$1.1M1 buy day
Sold$143.7M39 sell days
Net insider flow-$142.6Mnet selling · 5 years
Latest trade2026-11-10Farquhar John C.M.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Farquhar John C.M. | CEO | 38,900 | $55.74 | $2.2M | 1 |
| 2026-11-09 | Sell | Verghese Vikram | CFO | 3,587 | $53.15 | $190.6K | 1 |
| 2026-10-22 | Sell | Rogers Campbell | Other C-suite | 23,933 | $55.01 | $1.3M | 1 |
| 2026-10-12 | Sell | Farquhar John C.M. | CEO | 38,900 | $49.57 | $1.9M | 1 |
| 2026-09-18 | Sell | Rogers Campbell | Other C-suite | 19,682 | $50.15 | $987.1K | 1 |
| 2026-09-18 | Sell | Verghese Vikram | CFO | 16,766 | $50.75 | $850.9K | 1 |
| 2026-09-17 | Sell | Verghese Vikram | CFO | 7,579 | $50.11 | $379.8K | 1 |
| 2026-09-15 | Sell | Verghese Vikram | CFO | 668 | $50.01 | $33.4K | 1 |
| 2026-09-14 | Sell | Verghese Vikram | CFO | 4,593 | $50.24 | $230.7K | 1 |
| 2026-09-11 | Sell | Verghese Vikram | CFO | 29,714 | $50.06 | $1.5M | 1 |
| 2026-09-11 | Sell | Farquhar John C.M. | CEO | 3,890 | $50.00 | $194.5K | 1 |
| 2026-09-10 | Sell | Farquhar John C.M. | CEO | 35,010 | $46.42 | $1.6M | 1 |
| 2026-09-08 | Sell | Verghese Vikram | CFO | 6,640 | $50.03 | $332.2K | 1 |
| 2026-09-03 | Sell | Verghese Vikram | CFO | 27,540 | $49.69 | $1.4M | 1 |
| 2026-09-02 | Sell | Verghese Vikram | CFO | 5,876 | $50.60 | $297.3K | 1 |
| 2026-08-21 | Sell | Farquhar John C.M. | CEO | 27,230 | $50.00 | $1.4M | 1 |
| 2026-08-18 | Sell | Farquhar John C.M. | CEO | 32,676 | $45.00 | $1.5M | 1 |
| 2026-08-17 | Sell | Rogers Campbell | Other C-suite | 9,219 | $41.23 | $380.1K | 1 |
| 2026-08-14 | Sell | Farquhar John C.M. | CEO | 15,560 | $39.06 | $607.8K | 1 |
| 2026-08-10 | Sell | Farquhar John C.M. | CEO | 22,562 | $28.31 | $638.7K | 1 |
| 2026-07-15 | Sell | Rogers Campbell | Other C-suite | 9,219 | $25.72 | $237.1K | 1 |
| 2026-07-10 | Sell | Farquhar John C.M. | CEO | 22,562 | $27.75 | $626.1K | 1 |
| 2026-06-24 | Sell | Farquhar John C.M. | CEO | 38,900 | $35.00 | $1.4M | 1 |
| 2026-06-10 | Sell | Farquhar John C.M. | CEO | 22,562 | $28.50 | $643.0K | 1 |
| 2026-05-18 | Sell | Rogers Campbell | Other C-suite | 9,219 | $28.34 | $261.3K | 1 |
| 2026-05-11 | Sell | Farquhar John C.M. | CEO | 22,562 | $29.12 | $657.0K | 1 |
| 2026-04-30 | Sell | Bain Capital Life Sciences Investors, LLC | 10% owner | 948,757 | $29.23 | $27.7M | 2 |
| 2026-04-29 | Sell | Bain Capital Life Sciences Investors, LLC | 10% owner | 797,133 | $29.37 | $23.4M | 1 |
| 2026-04-28 | Sell | Bain Capital Life Sciences Investors, LLC | 10% owner | 254,110 | $30.51 | $7.8M | 1 |
| 2026-04-10 | Sell | Farquhar John C.M. | CEO | 22,562 | $26.72 | $602.9K | 1 |
| 2026-04-01 | Sell | Rogers Campbell | Other C-suite | 64,533 | $24.64 | $1.6M | 1 |
| 2026-03-19 | Sell | Rogers Campbell | Other C-suite | 64,533 | $25.69 | $1.7M | 1 |
| 2026-03-18 | Sell | Farquhar John C.M. | CEO | 9,725 | $25.00 | $243.1K | 1 |
| 2026-03-10 | Sell | Farquhar John C.M. | CEO | 12,837 | $22.66 | $290.9K | 1 |
| 2026-03-05 | Sell | Cullivan Julie A | Director | 9,122 | $25.00 | $228.0K | 1 |
| 2026-02-12 | Sell | Rogers Campbell | Other C-suite | 65,153 | $24.49 | $1.6M | 1 |
| 2026-02-10 | Sell | Farquhar John C.M. | CEO | 22,562 | $27.46 | $619.6K | 1 |
| 2026-02-05 | Sell | Cullivan Julie A | Director | 8,000 | $27.32 | $218.6K | 1 |
| 2026-02-04 | Sell | Bain Capital Life Sciences Investors, LLC | 10% owner | 2,000,000 | $28.05 | $56.1M | 1 |
| 2025-12-16 | Buy | Lightcap Jeffrey C | Director | 40,000 | $26.34 | $1.1M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10% owner | $0 | $115.0M | 2026-04-30 |
| Farquhar John C.M. | CEO | $0 | $15.0M | 2026-11-10 |
| Rogers Campbell | Other C-suite | $0 | $8.0M | 2026-10-22 |
| Verghese Vikram | CFO | $0 | $5.2M | 2026-11-09 |
| Lightcap Jeffrey C | Director | $1.1M | $0 | 2025-12-16 |
| Cullivan Julie A | Director | $0 | $446.6K | 2026-03-05 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.